Encompass Health Co. (NYSE:EHC) Shares Acquired by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC increased its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 165,894 shares of the company's stock after purchasing an additional 5,757 shares during the quarter. Segall Bryant & Hamill LLC owned 0.16% of Encompass Health worth $15,320,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Miracle Mile Advisors LLC boosted its holdings in shares of Encompass Health by 3.0% in the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock valued at $354,000 after acquiring an additional 112 shares in the last quarter. US Bancorp DE lifted its position in Encompass Health by 9.6% in the fourth quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after purchasing an additional 121 shares during the period. Signaturefd LLC boosted its holdings in Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares in the last quarter. CBIZ Investment Advisory Services LLC increased its position in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares during the period. Finally, MassMutual Private Wealth & Trust FSB raised its stake in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after buying an additional 137 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

Several research firms have issued reports on EHC. William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Royal Bank of Canada reiterated an "outperform" rating and set a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. KeyCorp lifted their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Finally, Barclays upped their target price on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health presently has an average rating of "Buy" and a consensus price target of $107.67.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.10% of the company's stock.

Encompass Health Price Performance

EHC stock traded down $0.39 during trading on Friday, hitting $100.75. The stock had a trading volume of 457,600 shares, compared to its average volume of 649,885. Encompass Health Co. has a 1-year low of $78.53 and a 1-year high of $104.55. The stock has a market cap of $10.15 billion, a price-to-earnings ratio of 22.59, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The company's 50 day moving average price is $98.67 and its two-hundred day moving average price is $97.46. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, sell-side analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is currently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.